MedTrace Logo

Aminophylline in Bradyasystolic Cardiac Arrest

NCT00312273 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 966

Last updated 2006-07-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of aminophylline in patients with out-of-hospital bradyasystolic cardiac arrest.

Conditions

  • Cardiac Arrest

Interventions

DRUG

Aminophylline (250mg IV +/- a second dose of 250mg IV)

Sponsors & Collaborators

  • Heart and Stroke Foundation of Canada

    collaborator OTHER

  • Vancouver Coastal Health Research Institute

    collaborator OTHER

  • Vancouver General Hospital

    lead OTHER

Principal Investigators

  • Riyad B Abu Laban, MD, MHSc · Department of Emergency Medicine, Vancouver General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Completion
2004-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00312273 on ClinicalTrials.gov